BR112014012524A2 - composições compreendendo um componente de estabilidade do prazo de validade - Google Patents

composições compreendendo um componente de estabilidade do prazo de validade

Info

Publication number
BR112014012524A2
BR112014012524A2 BR112014012524A BR112014012524A BR112014012524A2 BR 112014012524 A2 BR112014012524 A2 BR 112014012524A2 BR 112014012524 A BR112014012524 A BR 112014012524A BR 112014012524 A BR112014012524 A BR 112014012524A BR 112014012524 A2 BR112014012524 A2 BR 112014012524A2
Authority
BR
Brazil
Prior art keywords
compositions
life stability
stability component
component
shelf
Prior art date
Application number
BR112014012524A
Other languages
English (en)
Inventor
Ling Ching Ai
Hafezi Hooman
Schmidt Raymond
Original Assignee
Proteus Digital Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteus Digital Health Inc filed Critical Proteus Digital Health Inc
Publication of BR112014012524A2 publication Critical patent/BR112014012524A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3409—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of gases, e.g. fumigation; Compositions or apparatus therefor
    • A23L3/3418—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of gases, e.g. fumigation; Compositions or apparatus therefor in a controlled atmosphere, e.g. partial vacuum, comprising only CO2, N2, O2 or H2O
    • A23L3/3427—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of gases, e.g. fumigation; Compositions or apparatus therefor in a controlled atmosphere, e.g. partial vacuum, comprising only CO2, N2, O2 or H2O in which an absorbent is placed or used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/07—Endoradiosondes
    • A61B5/073—Intestinal transmitters
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04B—TRANSMISSION
    • H04B1/00—Details of transmission systems, not covered by a single one of groups H04B3/00 - H04B13/00; Details of transmission systems not characterised by the medium used for transmission
    • H04B1/02—Transmitters
    • H04B1/03—Constructional details, e.g. casings, housings
    • H04B1/034—Portable transmitters
    • H04B1/0343—Portable transmitters to be carried on the body

Abstract

compositions comprising a shelf-life stability component abstract of the disclosure compositions that include a shelf-life stability component are provided. in some instances, the compositions are ingestible compositions which include the shelf-life stability component and an ingestible component. aspects of the disclosure further include methods of making and using the compositions. tradução do resumo resumo patente de invenção: "composições compreendendo um componente de estabilidade do prazo de validade". composições que incluem um componente de estabilidade do prazo de validade são fornecidas. em alguns casos, as composições são composições ingeríveis, que incluem o componente de estabilidade do prazo de validade e um componente ingerível. aspectos da divulgação adicional incluem métodos de fazer e usar as composições.
BR112014012524A 2011-11-23 2012-11-21 composições compreendendo um componente de estabilidade do prazo de validade BR112014012524A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/304,260 US20130129869A1 (en) 2011-11-23 2011-11-23 Compositions comprising a shelf-life stability component
PCT/US2012/066392 WO2013078411A1 (en) 2011-11-23 2012-11-21 Compositions comprising a shelf-life stability component

Publications (1)

Publication Number Publication Date
BR112014012524A2 true BR112014012524A2 (pt) 2017-06-06

Family

ID=48427203

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014012524A BR112014012524A2 (pt) 2011-11-23 2012-11-21 composições compreendendo um componente de estabilidade do prazo de validade

Country Status (17)

Country Link
US (1) US20130129869A1 (pt)
EP (2) EP2782501A4 (pt)
JP (1) JP6276191B2 (pt)
KR (1) KR102056770B1 (pt)
CN (1) CN104066373B (pt)
AU (1) AU2012340578B2 (pt)
BR (1) BR112014012524A2 (pt)
CA (1) CA2856521C (pt)
HK (1) HK1198284A1 (pt)
IL (1) IL232731A0 (pt)
MX (1) MX338015B (pt)
PH (1) PH12014501158A1 (pt)
RU (1) RU2014120689A (pt)
SG (1) SG11201402594TA (pt)
TW (1) TWI659697B (pt)
WO (1) WO2013078411A1 (pt)
ZA (1) ZA201403794B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
AU2009281876B2 (en) 2008-08-13 2014-05-22 Proteus Digital Health, Inc. Ingestible circuitry
WO2010111403A2 (en) 2009-03-25 2010-09-30 Proteus Biomedical, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
CN102458236B (zh) 2009-04-28 2016-01-27 普罗秋斯数字健康公司 高可靠性的可摄入事件标记器及其使用方法
BR112012025650A2 (pt) 2010-04-07 2020-08-18 Proteus Digital Health, Inc. dispositivo ingerível miniatura
JP2014504902A (ja) 2010-11-22 2014-02-27 プロテウス デジタル ヘルス， インコーポレイテッド 医薬品を有する摂取可能なデバイス
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9271897B2 (en) 2012-07-23 2016-03-01 Proteus Digital Health, Inc. Techniques for manufacturing ingestible event markers comprising an ingestible component
SG11201503027SA (en) 2012-10-18 2015-05-28 Proteus Digital Health Inc Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
JP2016508529A (ja) 2013-01-29 2016-03-22 プロテウス デジタル ヘルス， インコーポレイテッド 高度に膨張可能なポリマーフィルムおよびこれを含む組成物
JP5941240B2 (ja) 2013-03-15 2016-06-29 プロテウス デジタル ヘルス， インコーポレイテッド 金属検出器装置、システム、および方法
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
WO2015112604A1 (en) * 2014-01-22 2015-07-30 Proteus Digital Health, Inc. Edible adhesives and ingestible compositions including the same
US11051543B2 (en) * 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
KR102051875B1 (ko) 2016-07-22 2019-12-04 프로테우스 디지털 헬스, 인코포레이티드 섭취 가능한 이벤트 마커의 전자기 감지 및 검출
EP3531901A4 (en) 2016-10-26 2021-01-27 Proteus Digital Health, Inc. CAPSULE PREPARATION PROCESSES WITH INGERABLE EVENT MARKERS
US11166939B2 (en) 2017-04-25 2021-11-09 Otsuka Pharmaceutical Co. Ltd Lisinopril compositions with an ingestible event marker
WO2018207257A1 (ja) * 2017-05-09 2018-11-15 大塚製薬株式会社 包装薬剤
US20200275687A1 (en) * 2017-05-09 2020-09-03 Arizona Board Of Regents On Behalf Of The University Of Arizona Edible materials and edible electrical systems made of same
US20240108269A1 (en) * 2020-12-16 2024-04-04 Nippon Telegraph And Telephone Corporation Bioelectrode and capacitor

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6607744B1 (en) * 2000-06-23 2003-08-19 Segan Industries Ingestibles possessing intrinsic color change
AU2001277163A1 (en) * 2000-07-24 2002-02-05 Motorola, Inc. Ingestible electronic capsule
US7916013B2 (en) * 2005-03-21 2011-03-29 Greatbatch Ltd. RFID detection and identification system for implantable medical devices
US6685452B2 (en) * 2001-04-26 2004-02-03 Chris C. Christiansen Implantable drug delivery pump with desiccant humidity protection
US6951536B2 (en) * 2001-07-30 2005-10-04 Olympus Corporation Capsule-type medical device and medical system
US20040008123A1 (en) * 2002-07-15 2004-01-15 Battelle Memorial Institute System and method for tracking medical devices
JP4733918B2 (ja) * 2003-10-01 2011-07-27 オリンパス株式会社 カプセル投薬システム
EP3827747A1 (en) * 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
ATE427898T1 (de) * 2005-11-18 2009-04-15 Airsec Sas Behalter und kapsel mit transponder
CA2645903A1 (en) * 2006-03-30 2007-10-11 Dow Global Technologies Inc. Method and system for monitoring and analyzing compliance with internal dosing regimen
EP2063766B1 (en) * 2006-09-06 2017-01-18 Innurvation, Inc. Ingestible low power sensor device and system for communicating with same
EP2087589B1 (en) 2006-10-17 2011-11-23 Proteus Biomedical, Inc. Low voltage oscillator for medical devices
EP2083680B1 (en) * 2006-10-25 2016-08-10 Proteus Digital Health, Inc. Controlled activation ingestible identifier
EP2069004A4 (en) 2006-11-20 2014-07-09 Proteus Digital Health Inc PERSONAL HEALTH SIGNAL RECEIVERS WITH ACTIVE SIGNAL PROCESSING
ES2930588T3 (es) * 2007-02-01 2022-12-19 Otsuka Pharma Co Ltd Sistemas de marcador de eventos ingeribles
KR101528748B1 (ko) 2007-02-14 2015-06-15 프로테우스 디지털 헬스, 인코포레이티드 고 표면적 전극을 갖는 체내 전원
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
EP2124725A1 (en) 2007-03-09 2009-12-02 Proteus Biomedical, Inc. In-body device having a multi-directional transmitter
FI2192946T3 (fi) 2007-09-25 2022-11-30 Elimistön sisäinen laite, jossa on virtuaalinen dipolisignaalinvahvistus
KR101586193B1 (ko) 2007-11-27 2016-01-18 프로테우스 디지털 헬스, 인코포레이티드 통신 채널을 이용한 트랜스바디 통신 시스템
AU2009221781B2 (en) 2008-03-05 2014-12-11 Otsuka Pharmaceutical Co., Ltd. Multi-mode communication ingestible event markers and systems, and methods of using the same
MY154234A (en) 2008-07-08 2015-05-15 Proteus Digital Health Inc Ingestible event marker data framework
AU2009281876B2 (en) * 2008-08-13 2014-05-22 Proteus Digital Health, Inc. Ingestible circuitry
KR20110081834A (ko) 2008-10-14 2011-07-14 프로테우스 바이오메디컬, 인코포레이티드 게임 환경에서 생리학적 데이터를 통합하기 위한 방법과 시스템
KR101192690B1 (ko) 2008-11-13 2012-10-19 프로테우스 디지털 헬스, 인코포레이티드 섭취 가능한 치료 활성화 시스템, 치료 장치 및 방법
US8055334B2 (en) 2008-12-11 2011-11-08 Proteus Biomedical, Inc. Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
TWI424832B (zh) 2008-12-15 2014-02-01 Proteus Digital Health Inc 與身體有關的接收器及其方法
EP3395333A1 (en) 2009-01-06 2018-10-31 Proteus Digital Health, Inc. Pharmaceutical dosages delivery system
AU2010203738B2 (en) 2009-01-06 2016-02-25 Otsuka Pharmaceutical Co., Ltd. High-throughput production of ingestible event markers
JP2012514799A (ja) 2009-01-06 2012-06-28 プロテウス バイオメディカル インコーポレイテッド 摂取に関連するバイオフィードバックおよび個別薬物療法の方法およびシステム
WO2010111403A2 (en) 2009-03-25 2010-09-30 Proteus Biomedical, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
CN102458236B (zh) * 2009-04-28 2016-01-27 普罗秋斯数字健康公司 高可靠性的可摄入事件标记器及其使用方法
US9149423B2 (en) * 2009-05-12 2015-10-06 Proteus Digital Health, Inc. Ingestible event markers comprising an ingestible component
TWI517050B (zh) 2009-11-04 2016-01-11 普羅托斯數位健康公司 供應鏈管理之系統
UA109424C2 (uk) * 2009-12-02 2015-08-25 Фармацевтичний продукт, фармацевтична таблетка з електронним маркером і спосіб виготовлення фармацевтичної таблетки
US20110243483A1 (en) * 2010-03-31 2011-10-06 Multisorb Technologies, Inc. Oxygen and carbon dioxide absorption in a single use container
BR112012025650A2 (pt) * 2010-04-07 2020-08-18 Proteus Digital Health, Inc. dispositivo ingerível miniatura

Also Published As

Publication number Publication date
JP2015506913A (ja) 2015-03-05
AU2012340578B2 (en) 2017-08-03
MX338015B (es) 2016-03-29
KR102056770B1 (ko) 2020-01-22
CN104066373B (zh) 2016-12-21
CA2856521C (en) 2020-09-08
JP6276191B2 (ja) 2018-02-07
TW201336432A (zh) 2013-09-16
ZA201403794B (en) 2017-08-30
CA2856521A1 (en) 2013-05-30
RU2014120689A (ru) 2015-12-27
US20130129869A1 (en) 2013-05-23
IL232731A0 (en) 2014-07-31
SG11201402594TA (en) 2014-09-26
HK1198284A1 (en) 2015-03-27
CN104066373A (zh) 2014-09-24
MX2014006302A (es) 2014-10-24
TWI659697B (zh) 2019-05-21
AU2012340578A1 (en) 2014-06-12
KR20140105772A (ko) 2014-09-02
WO2013078411A1 (en) 2013-05-30
EP2782501A1 (en) 2014-10-01
EP2782501A4 (en) 2015-08-12
EP3808257A1 (en) 2021-04-21
PH12014501158A1 (en) 2014-08-11

Similar Documents

Publication Publication Date Title
BR112014012524A2 (pt) composições compreendendo um componente de estabilidade do prazo de validade
CO7111285A2 (es) Composiciones pesticidas y procesos relacionados con ellas
ECSP14013302A (es) Composiciones de yodo-povidona estable
AR090465A1 (es) Formas solidas de un profarmaco de nucleotidos de tiofosforamidato
NZ702744A (en) D-amino acid compounds for liver disease
CR20150189A (es) Nanopartículas terapéuticas que comprenden un agente terapéutico y métodos para realizarlas y usarlas
BR112013020767A2 (pt) composições compreendendo ácido peróxi alfa-cetocarboxílico e métodos para a produção e o uso do mesmo
AR087745A1 (es) Composiciones y metodos que comprenden una variante de enzima lipolitica
CR20150277A (es) Piridina-2-amidas utiles como agonistas cb2
CO6680675A2 (es) Tidiazoles substituidos y composiciones pesticidas que los contienen
UA110470C2 (ru) Антидот антикоагулянта
CR20150250A (es) Nuevos derivados de piridina
BR112015018838A2 (pt) estabilidade melhorada de novas composições líquidas
EA201101117A1 (ru) Ингибиторы дпп-4 для лечения диабета у детей
BR112016023851A2 (pt) ?composição de revestimento de duas partes e método para revestir uma superfície?
MX2013004004A (es) Pirrolidinonas como inhibidores de metionina aminopeptidasa (metap-2).
CR20110660A (es) Mezclas fungicidas
BR112015023387A2 (pt) composições lipídicas de racecodotril
MX342947B (es) Tratamiento de diabetes tipo 2.
BR112012028037A2 (pt) formulação de pró-emulsão líquida de taxano não aquosa, métodos para administrar um taxano a um paciente e para fabricar uma formulação de pró-emulsão de taxano, composição de emulsão de taxano, e, kit
UY34420A (es) ?métodos de tratamiento del virus de la hepatitis c con que de gs-7977 y ribavirina, composiciones y usos"
NZ702934A (en) Racecadotril lipid compositions
UY34166A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
BR112015013178A2 (pt) composição e composição para uso para proteger um animal não humano contra a coccidiose
BR112015027824A2 (pt) composições de vitamina e em pó

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2494 DE 23-10-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.